Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Saori, Fukuda"'
Autor:
Saori Fukuda, Masanori Kugita, Kanako Kumamoto, Yuki Akari, Yuki Higashimoto, Shizuko Nagao, Takayuki Murata, Tetsushi Yoshikawa, Koki Taniguchi, Satoshi Komoto
Publikováno v:
Viruses, Vol 16, Iss 8, p 1198 (2024)
The live attenuated human rotavirus vaccine strain RIX4414 (Rotarix®) is used worldwide to prevent severe rotavirus-induced diarrhea in infants. This strain was attenuated through the cell culture passaging of its predecessor, human strain 89-12, wh
Externí odkaz:
https://doaj.org/article/3a7422a463114020bd489b9a564a38c9
Autor:
Yuuri Kurokawa, Ayako Watanabe, Yuka Kashiwabara, Saori Fukuda, Shohei Nomoto, Ayako Kuriki, Kenji Momo
Publikováno v:
Clinical Case Reports, Vol 12, Iss 2, Pp n/a-n/a (2024)
Key Clinical Message Most drugs that cause adverse events are difficult to identify in critically ill patients undergoing polypharmacy. We share our experience in identifying the causative drug among four suspect drugs administered during emergency t
Externí odkaz:
https://doaj.org/article/ad2f9d63c116482a882ec117036bbc80
Autor:
Kotone Nakanishi, Noriyuki Abe, Gaku Matsumoto, Nobuyoshi Noguchi, Saori Fukuda, Masashi Shimada, Mikio Kamioka
Publikováno v:
Tenri Medical Bulletin. 25:121-125
Autor:
Gaku Matsumoto, Noriyuki Abe, Kotone Nakanishi, Nobuyoshi Noguchi, Saori Fukuda, Masashi Shimada, Mikio Kamioka
Publikováno v:
Tenri Medical Bulletin. 25:126-132
Autor:
Saori Fukuda, Ratana Tacharoenmuang, Ratigorn Guntapong, Sompong Upachai, Phakapun Singchai, Tomihiko Ide, Riona Hatazawa, Karun Sutthiwarakom, Santip Kongjorn, Napa Onvimala, Kriangsak Ruchusatsawast, Pimpa Rungnopakun, Jutarat Mekmallika, Yoshiki Kawamura, Kazushi Motomura, Masashi Tatsumi, Naokazu Takeda, Takayuki Murata, Tetsushi Yoshikawa, Ballang Uppapong, Koki Taniguchi, Satoshi Komoto
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231099 (2020)
The emergence and rapid spread of unusual DS-1-like intergenogroup reassortant rotaviruses having G1/3/8 genotypes have been recently reported from major parts of the world (Africa, Asia, Australia, Europe, and the Americas). During rotavirus surveil
Externí odkaz:
https://doaj.org/article/3a356fe622de4036af9327515849bd87
Rapid Spread in Japan of Unusual G9P[8] Human Rotavirus Strains Possessing NSP4 Genes of E2 Genotype
Autor:
Saori, Fukuda, Yuki, Akari, Riona, Hatazawa, Manami, Negoro, Takaaki, Tanaka, Kazutoyo, Asada, Haruna, Nakamura, Katsumi, Sugiura, Masakazu, Umemoto, Haruo, Kuroki, Hiroaki, Ito, Shigeki, Tanaka, Mitsue, Ito, Tomihiko, Ide, Takayuki, Murata, Kiyosu, Taniguchi, Shigeru, Suga, Hajime, Kamiya, Takashi, Nakano, Koki, Taniguchi, Satoshi, Komoto
Publikováno v:
Japanese Journal of Infectious Diseases. 75:466-475
The emergence of unusual G9P[8]-E2 human rotaviruses in the Tokyo metropolitan area, Japan, in 2018 has been reported. During rotavirus strain surveillance in different regions of Japan (Mie, Okayama, and Chiba prefectures), G9P[8]-E2 strains were de
Publikováno v:
Viruses, Vol 13, Iss 9, p 1791 (2021)
Human rotaviruses (HuRVAs) are highly important causes of acute gastroenteritis in infants and young children worldwide. A lack of reliable and reproducible reverse genetics systems for HuRVAs has limited a proper understanding of HuRVA biology and a
Externí odkaz:
https://doaj.org/article/02f0352b178c49389e7e84178b5711ec
Publikováno v:
IDCases, Vol 8, Iss C, Pp 77-80 (2017)
Community-acquired methicillin-resistant Staphylococcus aureus has been spreading worldwide, including in Japan. However, few cases of toxic shock syndrome caused by Community-acquired methicillin-resistant Staphylococcus aureus have been reported in
Externí odkaz:
https://doaj.org/article/e43f6fdb3bda440db5e84a9ea2c6ba0b
Autor:
Saori Fukuda
Publikováno v:
SANGYO EISEIGAKU ZASSHI.
Autor:
Yoshiki Kawamura, Satoshi Komoto, Saori Fukuda, Masanori Kugita, Shuang Tang, Julianna Pieknik, Yasuko Enya, Masaru Ihira, Shizuko Nagao, Philip Krause, Koki Taniguchi, Tetsushi Yoshikawa
Publikováno v:
Open Forum Infectious Diseases. 9
Background Herpes simplex virus type 2 (HSV-2) can cause genital herpes, which reduces the patient's QOL associated with pain. In addition, genital herpes can increase the risk of human immunodeficiency virus infection. Vaccine development has been a